Estrategia de desarrollo clínico para la evaluación de la eficacia y seguridad de SURFACEN

Díaz-Casañas, Elaine; Morilla-Guzmán, Andrés Armando; Rodríguez-Moya, Valentín Santiago; Barrese-Pérez, Yinet.
Arch. méd. Camaguey ; 23(4)jul-ag 2019.
Artículo en Español | CUMED | ID: cum-76505

Documentos relacionados

  1. Target product profile: aerosolized surfactant for neonatal respiratory distress.
  2. Pulmonary Surfactants: a New Therapeutic Target in Asthma.
  3. A Quantitative Study of Transport of Surfactant Boli in a Three-Dimensional Lung Model of Neonates.
  4. Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits.
  5. Exogenous surfactant replacement immediately at birth as preventive therapy for lung prematurity in neonatal lambs.
  6. Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis.
  7. Efficacy and Safety of Two Different Flow Rates of Nasal High-Flow Therapy in Preterm Neonates ≥28 Weeks of Gestation: A Randomized Controlled Trial.
  8. Creation of a rating scale to teach Less Invasive Surfactant Administration (LISA) in simulation.
  9. Randomized Trial of Surfactant Therapy via Laryngeal Mask Airway Versus Brief Tracheal Intubation in Neonates Born Preterm.
  10. Management of respiratory distress in moderate and late preterm infants: clinical trajectories in the Neobs study.